Pharmaceutical
UK Start-up Targets Clinical Proof for Cannabis in Autism Spectrum Disorder
Kingdom Therapeutics, a UK-Irish biotech company, has passed a ‘major milestone’ in its ambitious journey towards launching clinical trials into cannabis and Autism Spectrum Disorder (ASD)